"FDA Recalls Some MiniMed Pumps for Death Risk; EDCs in Pet Poo"
The FDA issued a Class I recall for certain Medtronic MiniMed 600 series insulin pumps that give incorrect insulin dosing. So far there have been 2,175 injuries and one death reported. Combining a DYRK1A inhibitor molecule with a GLP-1 receptor agonist spurred human beta cell proliferation in vitro at rates of up to 6 percent a day. "With these drugs, if we increase beta cell replication rate to rates that will restore beta cell mass to normal, you'd have enough beta cells to fix your diabetes," said study author Andrew Stewart, MD, director of the Mount Sinai Diabetes, Obesity, and Metabolism Institute at the Icahn School of Medicine at Mount Sinai
— Andrew Stewart, MD, Professor, Medicine, Endocrinology, Diabetes and Bone Disease, Director, Diabetes, Obesity, Metabolism Institute, Icahn School of Medicine at Mount Sinai
Mount Sinai Researchers Move Closer to a Cure for Diabetes
Dec 10, 2024 View All Press Releases
Mount Sinai Discovers New Drug Combo to Induce High Rates of Human Beta Cell Regeneration
Feb 12, 2020 View All Press Releases